Authors
Loading...
Analysis reveals elevated MMP-1 levels as a poor prognostic factor in ovarian cancer, suggesting improved prediction when combined with CA125.
Hikino et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: